Opioid crisis: OxyContin maker Purdue Pharma will have to pursue profits even as a ‘public trust’

There have been two similar ambitious efforts to build alternatives to the profit-driven pharmaceutical model during and immediately after World War II.

David Herzberg, The Conversation

· Oct 24, 2020 · 11:30 pm